| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 17 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 17 |
| 2 | METHYLPREDNISOLONE | 14 |
| 3 | VORICONAZOLE | 13 |
| 4 | VORICONAZOLE INJECTION | 13 |
| 5 | TACROLIMUS | 12 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 12 |
| 7 | TACROLIMUS OINTMENT 0.1% | 12 |
| 8 | PREDNISOLONE | 10 |
| 9 | PREDNISOLONE ORAL | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM HYPOCHLORITE | 1 | 0.0038 |
| 1 | ETOPOSIDE PHOSPHATE | 4 | 0.0024 |
| 2 | IDELALISIB | 7 | 0.0010 |
| 3 | GANCICLOVIR SODIUM | 7 | 0.0007 |
| 4 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 5 | MICAFUNGIN SODIUM | 4 | 0.0006 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 7 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 8 | AMPHOTERICIN B | 6 | 0.0005 |
| 9 | VORICONAZOLE | 13 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 12 | 0.0005 |
| 1 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 6 | 0.0005 |
| 3 | Allylamine Antifungal [EPC] | 3 | 0.0004 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 5 | Azole Antifungal [EPC] | 24 | 0.0002 |
| 6 | Polyene Antifungal [EPC] | 6 | 0.0001 |
| 7 | Nucleoside Analog Antiviral [EPC] | 7 | 0.0001 |
| 8 | Glycopeptide Antibacterial [EPC] | 5 | 0.0001 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |